Patents Assigned to PrimeGen Biotech LLC
  • Patent number: 9657267
    Abstract: Methods are provided for the ex host maturation of immature germline cells into haploid gametes for restoration of fertility in patients in need thereof.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: May 23, 2017
    Assignee: PrimeGen Biotech LLC
    Inventors: Fariborz Izadyar, Johnny Yung-Chiong Chow, Constance Yuen
  • Patent number: 9629357
    Abstract: Disclosed herein are methods for cryopreserving cells and tissues under clinical conditions, allowing production of viable cell products suitable for transplantation.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: April 25, 2017
    Assignee: PrimeGen Biotech LLC
    Inventors: Fariborz Izadyar, Jason Pacchiarotti, Marnie Olmstead, Kyle Howerton, Thomas Ramos
  • Publication number: 20140220551
    Abstract: Disclosed herein are methods for cryopreserving cells and tissues under clinical conditions, allowing production of viable cell products suitable for transplantation.
    Type: Application
    Filed: February 3, 2014
    Publication date: August 7, 2014
    Applicant: PrimeGen Biotech LLC
    Inventors: Fariborz Izadyar, Jason Pacchiarotti, Marnie Olmstead, Kyle Howerton, Thomas Ramos
  • Patent number: 8119398
    Abstract: Compositions and methods for promoting tissue regeneration, particularly skin regeneration, with adipose-derived stem cells are provided. Additionally methods and compositions for promoting tissue regeneration with adipose-derived stem cell side population cells are provided. The adipose-derived cells are administered in a tissue regenerating effect amount optionally with a bioactive agent. Additionally the adipose derived cells can be autologous or syngeneic.
    Type: Grant
    Filed: December 30, 2005
    Date of Patent: February 21, 2012
    Assignee: PrimeGen Biotech LLC
    Inventors: Chauncey B. Sayre, Francisco J. Silva
  • Publication number: 20090263357
    Abstract: Therapeutically programmed cells and methods for making such cells are provided. Therapeutically programmed cells are stem cells which have been matured such that they represent either a more differentiated state or a less differentiated state after contact with stimulatory factors. The therapeutically reprogrammed cells are suitable for cellular regenerative therapy and have the potential to differentiate into more committed cell lineages. Additionally, hybrid stem cells suitable for therapeutic reprogramming and cellular regenerative therapy are provided.
    Type: Application
    Filed: January 11, 2008
    Publication date: October 22, 2009
    Applicant: PrimeGen Biotech, LLC
    Inventors: Chauncey B. Sayre, Francisco J. Silva
  • Publication number: 20070020759
    Abstract: Pluripotent therapeutically programmed cells and methods for making such cells are provided. The pluripotent therapeutically programmed cells are post-natal stem cells which have been matured such that they represent either a more differentiated state or a less differentiated state after contact with stimulatory factors. The pluripotent therapeutically reprogrammed cells are suitable for cellular regenerative therapy and have the potential to differentiate into more committed cell lineages. Also disclosed are culture media for therapeutically reprogramming post-natal stem cells.
    Type: Application
    Filed: July 17, 2006
    Publication date: January 25, 2007
    Applicant: PrimeGen Biotech LLC
    Inventors: Chauncey Sayre, Francisco Silva, Kwok-Yuen Pau
  • Publication number: 20060188491
    Abstract: Methods are provided for therapeutically reprogramming differentiated cells with nuclear extracts from pluripotent stem cells to generate a pluripotent epigenetic state in the differentiated cells. Additionally, therapeutically programmed cells for therapeutic use in patients are provided. Therapeutically programmed cells are stem cells which have been matured such that they represent either a more differentiated state or a less differentiated state after contact with stimulatory factors.
    Type: Application
    Filed: February 2, 2006
    Publication date: August 24, 2006
    Applicant: PrimeGen Biotech, LLC
    Inventors: Chauncey Sayre, Francisco Silva
  • Publication number: 20060147430
    Abstract: Compositions and methods for promoting tissue regeneration, particularly skin regeneration, with adipose-derived stem cells are provided. Additionally methods and compositions for promoting tissue regeneration with adipose-derived stem cell side population cells are provided. The adipose-derived cells are administered in a tissue regenerating effect amount optionally with a bioactive agent. Additionally the adipose derived cells can be autologous or syngeneic.
    Type: Application
    Filed: December 30, 2005
    Publication date: July 6, 2006
    Applicant: PrimeGen Biotech LLC
    Inventors: Chauncey Sayre, Francisco Silva
  • Publication number: 20050170506
    Abstract: Therapeutically programmed cells and methods for making such cells are provided. Therapeutically programmed cells are stem cells which have been matured such that they represent either a more differentiated state or a less differentiated state after contact with stimulatory factors. The therapeutically reprogrammed cells are suitable for cellular regenerative therapy and have the potential to differentiate into more committed cell lineages. Additionally, hybrid stem cells suitable for therapeutic reprogramming and cellular regenerative therapy are provided.
    Type: Application
    Filed: February 16, 2005
    Publication date: August 4, 2005
    Applicant: PrimeGen Biotech LLC
    Inventors: Chauncey Sayre, Francisco Silva